Vegetalization of the Maternal Diet During Pregnancy: Association With Pregnancy Outcomes and Newborn Health.
NCT ID: NCT06155344
Last Updated: 2024-04-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
670 participants
OBSERVATIONAL
2024-03-18
2026-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Low Glycemic Load Diet During Pregnancy in Overweight Women
NCT00364403
Impact of a Nutritional Intervention Program for Weight Control During Pregnancy
NCT00634530
Effects of Diet on Pregnancy Outcome and Child Obesity
NCT03232762
Dietry Pattern and Lead Levels in Pregnancy
NCT03408275
Dietary Salicylates and Preeclampsia
NCT06239363
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pregnant women included in the VEGALIM project
Pregnant women consulting CEMAFOER (Center for Maternal and Fetal Pathology Screening and Risk Assessment) of Nantes University Hospital for pregnancy monitoring
Food Frequency Questionnaire
We will obtain a global index of vegetalization of the diet (the Plant based Diet Index: PDI) from data obtained using semi-quantitative questionnaires on food frequency (Food Frequency Questionnaire (FFQ)) validated on the national ELFE cohort (French Longitudinal Study from Childhood (https://www.elfe-france.fr)) and completed by women in the 1st trimester of pregnancy (T1) and at delivery.
Collection of 4 mL maternal blood
One tube collection of 4 mL maternal blood in the first trimester and at delivery.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Food Frequency Questionnaire
We will obtain a global index of vegetalization of the diet (the Plant based Diet Index: PDI) from data obtained using semi-quantitative questionnaires on food frequency (Food Frequency Questionnaire (FFQ)) validated on the national ELFE cohort (French Longitudinal Study from Childhood (https://www.elfe-france.fr)) and completed by women in the 1st trimester of pregnancy (T1) and at delivery.
Collection of 4 mL maternal blood
One tube collection of 4 mL maternal blood in the first trimester and at delivery.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Gestational age between 11 and 13 AW +6 days
* Understanding French
Exclusion Criteria
* Patient who objected to being included in the study
* Patient with cognitive problems that prevent her from answering questionnaires
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
UMR 1280 PHAN
UNKNOWN
INRAE - CRESS
UNKNOWN
Nantes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Norbert Winer, MD, PHD
Role: PRINCIPAL_INVESTIGATOR
Nantes University Hospital
Veronique Ferchaud-Roucher, PhD
Role: STUDY_DIRECTOR
UMR 1280 PHAN
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Nantes
Nantes, Loire-Atlantique, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-A01997-38
Identifier Type: OTHER
Identifier Source: secondary_id
RC23_0399
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.